Thankfully, most GLP-1 shortages have been resolved since early 2025, but a shortage can also drive people to switch from tirzepatide to semaglutide, or semaglutide to tirzepatide
These precedents support the argument that weight loss drugs have a history of hiding long-term complications, and courts have consistently held companies liable for failure to disclose such risks
217 Today: Weight-loss drug coverage for Illinois state workers could cost hundreds of millions of dollars Wednesday, May 1, 2024 Today's headlines: The Abraham Lincoln Presidential Library and Museum is now home to a document that historians say helped start the Civil War
This does not mean a medicine is always unsafe for them, but it does mean the risk-benefit review should be individualized
Our weight loss program in University of California-Santa Barbara, California employs weight loss experts who understand that each patient's body reacts differently to medications, and what works well for one person may not be suitable for another
Cancer Cell 26 , 331343 (2014)
